StockNews.com Begins Coverage on Cutera (NASDAQ:CUTR)

Research analysts at StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Price Performance

Shares of CUTR stock opened at $0.04 on Wednesday. The firm’s 50-day simple moving average is $0.32 and its 200-day simple moving average is $0.46. Cutera has a 1-year low of $0.09 and a 1-year high of $3.00. The firm has a market cap of $787,254.00, a P/E ratio of -0.01 and a beta of 1.36.

Institutional Trading of Cutera

An institutional investor recently bought a new position in Cutera stock. Sculptor Capital LP purchased a new stake in shares of Cutera, Inc. (NASDAQ:CUTR) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned 0.82% of Cutera at the end of the most recent quarter. 90.70% of the stock is currently owned by institutional investors and hedge funds.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.